Psyence Biomedical earnings were $1.0M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest PBM earnings report on Mar 31, 2025 announced Q1 2025 earnings of N/A, down N/A from last quarter. For the last reported fiscal year 2025 ending Mar 31, 2025, PBM reported annual earnings of $1.0M, with -102% growth.
PBM past earnings growth
How has PBM's earnings growth performed historically?
What were Psyence Biomedical's earnings last quarter?
Psyence Biomedical (NASDAQ: PBM) reported Q1 2025 earnings per share (EPS) of N/A, up N/A year over year. Total PBM earnings for the quarter were N/A. In the same quarter last year, Psyence Biomedical's earnings per share (EPS) was N/A.
As of the last Psyence Biomedical earnings report, Psyence Biomedical is currently profitable. Psyence Biomedical's net profit (also called net income) for the twelve months ending Mar 31, 2025 was $1.01 million, a 101.98% decrease year over year.
What was PBM's earnings growth in the past year?
As of Psyence Biomedical's earnings date in Q3 2025, Psyence Biomedical's earnings has grown year over year. PBM earnings in the past year totalled $1.01 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.